Genaissance Pharmaceuticals, Inc.
🏢 View company profile →11Patents
0Active
11Granted
33Portfolio score
Filing activity: Dec 10, 1997 → Aug 30, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7058517B1 | Methods for obtaining and using haplotype data | Emerging Cross-Sectional Technologies | 143 | Expired |
| US6931326B1 | Methods for obtaining and using haplotype data | Emerging Cross-Sectional Technologies | 73 | Expired |
| US6521747B2 | Haplotypes of the AGTR1 gene | Physics | 29 | Expired |
| US6944767B1 | Methods and apparatus for ensuring the privacy and security of personal medical information | Electricity | 25 | Expired |
| US5972614A | Genome anthologies for harvesting gene variants | Chemistry; Metallurgy | 21 | Expired |
| US6232076A | Stabilizer of dye sequencing products | Chemistry; Metallurgy | 11 | Expired |
| US6797477B2 | Genetic typing of the human cytochrome P450 2A6 gene and related methods | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6861217B1 | Variation in drug response related to polymorphisms in the β2-adrenergic receptor | Chemistry; Metallurgy | 8 | Expired |
| US6586183B2 | Association of &bgr;2-adrenergic receptor haplotypes with drug response | Chemistry; Metallurgy | 6 | Expired |
| US6797472B1 | Variation in drug response related to polymorphisms in &bgr;2-adrenergic receptor | Chemistry; Metallurgy | 4 | Expired |
| US6929912B2 | Methods for evaluating the ability to metabolize pharmaceuticals | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.